Jim Simons’s Akcea Therapeutics Inc AKCA Stock Holding History

Jim Simons’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-274,404	Closed	-$4.98M	–	3879
2020 Q3	$4.98M	Sell	274,404 -26,100	-9%	-$370K	0.01%	1575
2020 Q2	$4.12M	Buy	300,504 +266,104	+774%	+$4.11M	﹤0.01%	1761
2020 Q1	$492K	Sell	34,400 -35,800	-51%	-$588K	﹤0.01%	2763
2019 Q4	$1.19M	Buy	+70,200	New	+$1.31M	﹤0.01%	2550
2019 Q3	–	Sell	-19,200	Closed	-$450K	–	3842
2019 Q2	$450K	Buy	+19,200	New	+$474K	﹤0.01%	3036

Jim Simons's AKCA Position: Q4 2020 in Review

Jim Simons sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 274,404 shares — an estimated $4.98M sold.

Jim Simons first reported a position in AKCA in Q2 2019 and held it in 5 quarters. The position peaked at $4.98M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Jim Simons reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Jim Simons sold 274,404 Akcea Therapeutics Inc shares in Q4 2020, an estimated $4.98M.
Jim Simons first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 5 quarters.
Jim Simons's Akcea Therapeutics Inc position peaked at $4.98M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.